Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
- PMID: 37035491
- PMCID: PMC10077831
- DOI: 10.1093/ofid/ofad131
Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
Abstract
Background: Severe respiratory syncytial virus (RSV)-associated pneumonia in adults has rarely been addressed. We investigated the burden and clinical characteristics of severe RSV-associated pneumonia in critically ill adult patients.
Methods: We analyzed a prospective cohort of 2865 adults with severe pneumonia who were admitted to the intensive care unit in a 2700-bed tertiary care hospital from 2010 to 2019. The epidemiology, characteristics, and outcomes of 92 cases of severe RSV-associated pneumonia and 163 cases of severe influenza virus (IFV)-associated pneumonia were compared.
Results: Of 1589 cases of severe community-acquired pneumonia, the incidence of RSV-associated pneumonia was less than half that of IFV-associated pneumonia (3.4% vs 8.1%). However, among 1276 cases of severe hospital-acquired pneumonia (HAP), there were slightly more cases of RSV-associated than IFV-associated pneumonia (3.8% vs 3.5%). During the 9 epidemic seasons, RSV-A (5 seasons) and RSV-B (4 seasons) predominated alternately. Structural lung disease, diabetes mellitus, and malignancy were common underlying diseases in both groups. Immunocompromise (57.6% vs 34.4%; P < .001) and hospital acquisition (47.8% vs 23.9%; P < .001) were significantly more common in the RSV group. Coinfection with Streptococcus pneumoniae (3.3% vs 9.8%; P = .08) and methicillin-susceptible Staphylococcus aureus (1.1% vs 6.8%; P = .06) tended to be less frequent in the RSV group. The 90-day mortality was high in both groups (39.1% vs 40.5%; P = .89).
Conclusions: RSV infection was associated with substantial morbidity and mortality in critically ill adult patients, similar to IFV. The relatively higher incidence of RSV in severe HAP suggests that the transmissibility of RSV can exceed that of IFV in a hospital setting.
Keywords: hospital-acquired pneumonia; influenza; intensive care unit; respiratory syncytial virus; severe adult pneumonia.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors report no potential conflicts.
Figures



Similar articles
-
Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia.J Clin Virol. 2015 Jan;62:41-7. doi: 10.1016/j.jcv.2014.11.010. Epub 2014 Nov 15. J Clin Virol. 2015. PMID: 25542469 Free PMC article.
-
Respiratory syncytial virus burden among adults during flu season: an underestimated pathology.J Hosp Infect. 2018 Dec;100(4):463-468. doi: 10.1016/j.jhin.2018.03.034. Epub 2018 Mar 31. J Hosp Infect. 2018. PMID: 29614245
-
Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults.J Clin Virol. 2019 Aug;117:1-4. doi: 10.1016/j.jcv.2019.05.007. Epub 2019 May 15. J Clin Virol. 2019. PMID: 31128379 Free PMC article.
-
Microorganisms associated with respiratory syncytial virus pneumonia in the adult population.Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):157-160. doi: 10.1007/s10096-018-3407-3. Epub 2018 Oct 23. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30353485 Free PMC article.
-
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.Clin Microbiol Infect. 2017 Apr;23(4):253-259. doi: 10.1016/j.cmi.2016.11.014. Epub 2016 Nov 27. Clin Microbiol Infect. 2017. PMID: 27903461 Free PMC article.
Cited by
-
Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm.Viruses. 2023 Jul 31;15(8):1676. doi: 10.3390/v15081676. Viruses. 2023. PMID: 37632017 Free PMC article. Review.
-
Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults.Infect Chemother. 2024 Mar;56(1):1-12. doi: 10.3947/ic.2024.0011. Epub 2024 Mar 12. Infect Chemother. 2024. PMID: 38527779 Free PMC article. Review.
-
Severe respiratory syncytial virus disease.J Intensive Med. 2024 Apr 20;4(4):405-416. doi: 10.1016/j.jointm.2024.03.001. eCollection 2024 Oct. J Intensive Med. 2024. PMID: 39310066 Free PMC article. Review.
-
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.Vaccines (Basel). 2025 Mar 19;13(3):328. doi: 10.3390/vaccines13030328. Vaccines (Basel). 2025. PMID: 40266222 Free PMC article.
-
Respiratory syncytial virus: an under-recognized healthcare-associated infection.Infect Control Hosp Epidemiol. 2025 May 16;46(6):1-5. doi: 10.1017/ice.2025.88. Online ahead of print. Infect Control Hosp Epidemiol. 2025. PMID: 40376828 Free PMC article.
References
-
- Collins PL, Karron RA. Respiratory syncytial virus and metapneumovirus. In Knipe DM, Howley PM, editors. Fields Virology. 6th ed. Vol. 1. Wolters Kluwer Health Adis;2013; 1443–85.
-
- Li Y, Reeves RM, Wang X, et al. . Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 2019; 7:e1031–45. - PubMed
-
- Shi T, Denouel A, Tietjen AK, et al. . Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis 2020; 222:S577–83. - PubMed
-
- Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–59. - PubMed